(Q38085222)

28 August 2017

title

Adverse drug events as a cause of hospitalization in older adults (English)

1 reference

28 August 2017

1 reference

5

Fabrizia Lattanzio

1 reference

28 August 2017

6

Antonio Cherubini

1 reference

28 August 2017

Fabio Salvi

1

1 reference

28 August 2017

Annalisa Marchetti

series ordinal

2

1 reference

28 August 2017

Federica D'Angelo

series ordinal

3

1 reference

28 August 2017

Massimo Boemi

series ordinal

4

1 reference

28 August 2017

publication date

1 January 2012

1 reference

28 August 2017

1 reference

28 August 2017

volume

35 Suppl 1

1 reference

28 August 2017

page(s)

29-45

1 reference

Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Determinants of under-reporting of adverse drug reactions: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Contribution of adverse drug reactions to hospital admission of older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug events as a cause of hospital admission in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Contribution of drug related problems to hospital admission in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Emergency hospitalizations for adverse drug events in older Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

National surveillance of emergency department visits for outpatient adverse drug events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Pharmacoeconomics and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Which drugs cause preventable admissions to hospital? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Detection of patients presenting with adverse drug events in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Apixaban in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Antiplatelet and Anticoagulant Therapy in Patients With Gastrointestinal Bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Optimal management of peptic ulcer disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Managing adverse effects and drug-drug interactions of antiplatelet agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Drug-drug interactions among elderly patients hospitalized for drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Clinical review: Drug-induced hypoglycemia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Evaluations of hospitalizations associated with thiazide-associated hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Lipid lowering for secondary prevention of cardiovascular disease in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Renal adverse effects of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Survey of patient knowledge related to acetaminophen recognition, dosing, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Treatment guidelines for the pharmacological management of pain in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Antipsychotic-induced hyponatraemia: a systematic review of the published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Meta-analysis of the impact of 9 medication classes on falls in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Medication and falls: risk and optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Associations between drug burden index and falls in older people in residential aged care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Drug Burden Index and hospitalization among community-dwelling older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Risk of death in elderly users of conventional vs. atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Atypical antipsychotic drugs and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Study Findings Hard to Interpret—Reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Antipsychotic drug use and risk of pneumonia in elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Pharmacotherapy and the risk for community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Lithium toxicity profile: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Polypharmacy in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Potentially harmful drug-drug interactions in the elderly: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Prevalence of potentially hazardous drug interactions amongst Australian veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Fighting against age discrimination in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Inappropriate prescribing in the older population: need for new criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Inappropriate medication use among the elderly: a systematic review of administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Potentially inappropriate medication in elderly hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Is inappropriate medication use a major cause of adverse drug reactions in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Appropriate prescribing in elderly people: how well can it be measured and optimised?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Inappropriate prescribing: criteria, detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Inappropriate prescribing and adverse drug events in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Inappropriate prescribing predicts adverse drug events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Beyond the prescription: medication monitoring and adverse drug events in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Incidence and preventability of adverse drug events among older persons in the ambulatory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse Drug Events in Ambulatory Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Medication use leading to emergency department visits for adverse drug events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Optimising drug treatment for elderly people: the prescribing cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Preventing medical injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Effect of bar-code technology on the safety of medication administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Hospital admissions resulting from preventable adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Medication adherence to multidrug regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Evidence-based strategies for the optimization of pharmacotherapy in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Preventable adverse drug events and their causes and contributing factors: the analysis of register data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Adverse drug reactions in older people: detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Medication errors: the importance of an accurate drug history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Recording previous adverse drug reactions--a gap in the system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Guidelines for prevention of NSAID-related ulcer complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Reconsidering medication appropriateness for patients late in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Interventions that can reduce inappropriate prescribing in the elderly: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Electronic prescribing and other forms of technology to reduce inappropriate medication use and polypharmacy in older people: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Effect of computerized physician order entry and a team intervention on prevention of serious medication errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Medication withdrawal trials in people aged 65 years and older: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Predicting and detecting adverse drug reactions in old age: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Making inpatient medication reconciliation patient centered, clinically relevant and implementable: a consensus statement on key principles and necessary first steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Interventions to enhance medication adherence in chronic medical conditions: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

Drug-Induced Lithium Toxicity in the Elderly: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03319101

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

12 December 2020

Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

1 reference

12 December 2020

Conventional and Atypical Antipsychotics and the Risk of Hospitalization for Ventricular Arrhythmias or Cardiac Arrest

1 reference

12 December 2020

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine

1 reference

12 December 2020

STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation

1 reference

12 December 2020

Effect of admission medication reconciliation on adverse drug events from admission medication changes

1 reference

12 December 2020

Pharmacological management of persistent pain in older persons

1 reference

12 December 2020

Adverse drug reactions in older patients during hospitalisation: are they predictable?

1 reference

12 December 2020

Interventions to improve the appropriate use of polypharmacy for older people

1 reference

12 December 2020

Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study

1 reference

12 December 2020

Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.

1 reference

12 December 2020

1 reference

12 December 2020

Acute admissions to a geriatric assessment unit

1 reference

12 December 2020

Optimizing Medication Adherence in Older Patients: A Systematic Review

1 reference

12 December 2020

Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria

1 reference

12 December 2020

Medication errors observed in 36 health care facilities

1 reference

12 December 2020

Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

1 reference

12 December 2020

Antipsychotic use and myocardial infarction in older patients with treated dementia

1 reference

12 December 2020

Adverse drug reactions as a cause for admissions to a department of internal medicine

1 reference

12 December 2020

Evaluation of outpatient adverse drug reactions leading to hospitalization.

1 reference

12 December 2020

Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe

1 reference

12 December 2020

Explicit criteria for determining potentially inappropriate medication use by the elderly. An update

1 reference

12 December 2020

Patient-reported medication symptoms in primary care.

1 reference

12 December 2020

Interventions for enhancing medication adherence

1 reference

12 December 2020

Polypharmacy, adverse drug reactions, and geriatric syndromes

1 reference

12 December 2020

Risk of cerebrovascular accident associated with use of antipsychotics: population-based case-control study

1 reference

12 December 2020

The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure

1 reference

12 December 2020

Association between acute geriatric syndromes and medication-related hospital admissions

1 reference

12 December 2020

1 reference

12 December 2020

Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries

1 reference

12 December 2020

Using pharmacogenetics knowledge to increase accuracy of alerts for adverse drug events

1 reference

12 December 2020

The epidemiology and type of medication errors reported to the National Poisons Information Centre of Ireland

1 reference

12 December 2020

Drug combinations and impaired renal function -- the 'triple whammy'

1 reference

12 December 2020

Contribution of Renal Impairment to Potentially Preventable Medication-Related Hospital Admissions

1 reference

12 December 2020

Characteristics of patients with sulphonurea-induced hypoglycemia

1 reference

12 December 2020

Therapeutic failure-related hospitalisations in the frail elderly

1 reference

12 December 2020

Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies

1 reference

12 December 2020

FDA: Antipsychotics risky for elderly

1 reference

12 December 2020

Potentially Inappropriate Drug Prescriptions and Risk of Hospitalization among Older, Italian, Nursing Home Residents

1 reference

12 December 2020

Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03319101

1 reference

Dimensions Publication ID

28 August 2017

1014512552

0 references

1 reference